
Rafarma Pharmaceuticals
(OTC) RAFA
Rafarma Pharmaceuticals Financials at a Glance
Market Cap
$6.42M
Revenue (TTM)
$9.14M
Net Income (TTM)
$306.00K
EPS (TTM)
$0.00
P/E Ratio
19.68
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$0.07
Volume
553
Open
$0.07
Price
$0.07
Volume
553
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.00 - $0.15
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$0.07
Volume
553
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.00 - $0.15
RAFA News
RAFA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rafarma Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Raivo Unt
Website
www.rafarma.comHeadquarters
Sandy, UT 84070, US
RAFA Financials
Key Financial Metrics (TTM)
Gross Margin
7%
Operating Margin
5%
Net Income Margin
3%
Return on Equity
3%
Return on Capital
4%
Return on Assets
2%
Earnings Yield
5.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.42M
Shares Outstanding
93.17M
Volume
553
Short Interest
0.00%
Avg. Volume
27.36K
Financials (TTM)
Gross Profit
$674.00K
Operating Income
$405.00K
EBITDA
$342.00K
Operating Cash Flow
$44.00K
Capital Expenditure
$44.00K
Free Cash Flow
$0.00
Cash & ST Invst.
$77.00K
Total Debt
$0.00
Rafarma Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$278.00K
+26.4%
Gross Profit
$119.00K
+63.0%
Gross Margin
42.81%
N/A
Market Cap
$6.42M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$74.00K
+117.6%
EBITDA
$92.00K
+19.8%
Quarterly Fundamentals
Net Cash
$77.00K
+16.7%
Accounts Receivable
$1.62M
-13.8%
Inventory
$156.00K
+67.7%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
2.40%
N/A
Return on Invested Capital
4.13%
N/A
Free Cash Flow
$1.00K
-100.6%
Operating Cash Flow
$1.00K
-100.6%